Short-term Safety of Augmentation Mammaplasty Using the BellaGel Implants in Korean Women.

Autor:	Sung JY; BBC Plastic Surgery Clinic, Changwon, South Korea., Jeong JP; Samsungyubang Breast Clinic, Busan, South Korea., Moon DS; Goeun Lift Cosmetic Surgical Clinic, Busan, South Korea., Kim MS; Korean Society of Breast Implant Research, Seoul, South Korea., Kim HC; Gangnam Picasso Clinic, Seoul, South Korea., Choi WS; Lamar Clinic, Ulsan, South Korea., Song KY; Department of Breast Surgery, Gwangju Suwan Hospital, Gwangju, South Korea., Kim HJ; Korean Society of Breast Implant Research, Seoul, South Korea., Lim HG; Department of Radiology, Gwangju Suwan Hospital, Gwangju, South Korea., Kim JH; The W Clinic, Seoul, South Korea.
Jazyk:	angličtina
Zdroj:	Plastic and reconstructive surgery. Global open [Plast Reconstr Surg Glob Open] 2019 Dec 24; Vol. 7 (12), pp. e2566. Date of Electronic Publication: 2019 Dec 24 (Print Publication: 2019).
DOI:	10.1097/GOX.0000000000002566
Abstrakt:	Asian women are stereotypically characterized by a slim body, smaller breasts and areolae, and larger nipples when compared with White women. They would therefore be vulnerable to displacement of a breast implant if they receive larger implants. They are also prone to hypertrophic and prolonged hyperemic scars. Surgeons should therefore be aware of Asian women's breast anatomy, healing tendency, and preferences. We conducted this multicenter, retrospective study to assess the short-term safety of the BellaGel implants in Korean women. Methods: We evaluated a total of 637 women (n = 637; 1,274 breasts) for incidences of postoperative complications and the cumulative Kaplan-Meier complication-free survival. Results: Overall, there were 12 cases (1.9%) of postoperative complications; these include 6 cases (0.9%) of hematoma, 2 cases (0.3%) of infection, and 4 cases (0.6%) of seroma. Moreover, there was no significant difference in the cumulative complication-free survival at 120 weeks between the 4 types of the BellaGel implants (χ 2 = 2.289, P = 0.513). Conclusion: In conclusion, we describe the short-term safety of augmentation mammaplasty using the BellaGel implants in Korean women. But further prospective, large-scale, multicenter studies with a long period of follow-up are warranted to establish our results. Competing Interests: Disclosure: The authors have no financial interest to declare in relation to the content of this article. (Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu